Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Stan Z. Gertler"'
Autor:
Sasha Mazzarello, Stan Z. Gertler, Angel Arnaout, Tim Ramsay, Susan Dent, Mohammed F.K. Ibrahim, John Hilton, Roanne J. Segal, Susan J. Robertson, Ranjeeta Mallick, Lisa Vandermeer, Mark Clemons, Sandeep Sehdev, Dean Fergusson, Brian Hutton, Carol Stober, Zuzana Kos
Publikováno v:
Journal of Evaluation in Clinical Practice. 25:196-204
OBJECTIVE The three Magee Equations provide an estimate of the Oncotype DX recurrence score using commonly available clinicopathologic information (tumour size, grade, oestrogen receptor, progesterone receptor, HER2, and Ki67). We assessed whether in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff37bb1d277f572a8023bb36df3d36f
https://doi.org/10.1111/jep.13094
https://doi.org/10.1111/jep.13094
Autor:
Lisa Vandermeer, John Hilton, Sasha Mazzarello, Mihaela Mates, Dean Fergusson, Tina Hsu, Mohammed F.K. Ibrahim, Mark Clemons, Stan Z. Gertler, Andrew Robinson, Ranjeeta Mallick, Brian Hutton, Carol Stober, Nadia Califaretti
Publikováno v:
Breast Cancer Research and Treatment. 168:371-379
The most effective duration of filgrastim as primary febrile neutropenia (FN) prophylaxis in early breast cancer (EBC) patients is unknown. Despite significant differences in cost and toxicity, no prospective trial has been performed to optimize prac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be2a7b2df0e0ec8df4e83542a4b90329
https://doi.org/10.1007/s10549-017-4604-y
https://doi.org/10.1007/s10549-017-4604-y
Autor:
Stan Z. Gertler, Sasha Mazzarello, Lisa Vandermeer, David Cella, Mark Clemons, Susan Dent, S. Verma, Iryna Kuchuk, Nathaniel Bouganim, Xinni Song, G. Dranitsaris, S. Simos, Stephanie Smith, Carmel Jacobs
Publikováno v:
Breast Cancer Research and Treatment. 155:77-84
Previous studies suggest switching from pamidronate to a more potent bone-targeted agent is associated with biomarker and palliative response in breast cancer patients with bone metastases. Until now, this has not been addressed in a double-blind, ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::125b8a1c40f2017903b08b6f815ef7c6
https://doi.org/10.1007/s10549-015-3646-2
https://doi.org/10.1007/s10549-015-3646-2
Autor:
N. Graham, Susan Dent, Dominique Frechette, Stan Z. Gertler, Shailendra Verma, Paul Wheatley-Price, Mark Clemons, Lise Paquet, Xinni Song
Publikováno v:
Breast Cancer Research and Treatment. 141:111-117
The goal of this project was to investigate the contentious issue of a possible effect of endocrine therapy (ET) on sexual dysfunction (SD) in postmenopausal early stage breast cancer survivors. To date, few studies have assessed sexual functioning p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ce275f95932c157664cd1433609c28c
https://doi.org/10.1007/s10549-013-2659-y
https://doi.org/10.1007/s10549-013-2659-y
Autor:
Howard Lesiuk, Zhi-Gao Huang, Dong Xue, Stan Z. Gertler, Alastair M. Buchan, Hui Li, Kimberley Barnes, Karen E. Chaundy
SNX-111 (NEUREX Corporation, Menlo Park, CA, U.S.A.) an ω-conopeptide, was tested for cytoprotection following normothermic ischemia using both a four-vessel occlusion model of severe forebrain ischemia and a model of transient middle cerebral arter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bd467c9e9c64fba26170cd4463d4dd7
https://ora.ox.ac.uk/objects/uuid:e07e6211-1028-4d88-9e94-02260af204ef
https://ora.ox.ac.uk/objects/uuid:e07e6211-1028-4d88-9e94-02260af204ef
We investigated the putative role of nitric oxide in the expression of neuronal injury following both transient severe forebrain ischemia (CA1 neuronal injury) and transient or permanent middle cerebral artery occlusion (neocortical pannecrosis). Usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d111de39e3e99228550376bef70c35
https://ora.ox.ac.uk/objects/uuid:f041acfd-7f89-4c0e-b4fc-1b252767f6c2
https://ora.ox.ac.uk/objects/uuid:f041acfd-7f89-4c0e-b4fc-1b252767f6c2
Autor:
Mark Clemons, Stan Z. Gertler, Xinni Song, Angel Arnaout, Femina Kanji, Nathaniel Bouganim, Rosalind A. Segal, Susan Dent, Iryna Kuchuk, Gregory R. Pond, S. Verma
Publikováno v:
Current Oncology
Volume 23
Issue 3
Pages 2394-279
Volume 23
Issue 3
Pages 2394-279
The accrual rate to clinical trials in oncology remains low. In this exploratory pilot study, we prospectively assessed the role that engaging a referring surgeon plays in enhancing nonsurgical oncologic clinical trial accrual. Newly diagnosed breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f52932050eb075e29cb02f5d4e51b9
Autor:
Jean Powers, Robert Stagg, Stan Z. Gertler, Warren P. Mason, Sarah Kirby, Matthew Wright, Jacinta Aniagolu, Elizabeth Eisenhauer, Peter A. Forsyth, Christopher Watling
Publikováno v:
Neuro-Oncology. 7:183-188
We studied the activity of T138067-sodium in patients with malignant gliomas. T138067-sodium is a unique new chemotherapy agent that inhibits microtubule formation by binding irreversibly and specifically to beta(1), beta(2)and beta(4) isotypes of 3-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::006e6d0f771b227111359daf05928801
https://doi.org/10.1215/s1152851704000602
https://doi.org/10.1215/s1152851704000602
Autor:
Nancy Wainman, Gregory Cairncross, Karl Belanger, Samuel K. Ludwin, Elizabeth Eisenhauer, David R. Macdonald, Stan Z. Gertler, Peter A. Forsyth, Susan Burdette-Radoux, Julie Bergeron, Denis Soulières
Publikováno v:
Investigational New Drugs. 21:473-480
To determine the efficacy and toxicity of a novel chemotherapeutic approach with topotecan, a camptothecin analog, for progressive or recurring anaplastic oligodendroglioma or mixed oligoastrocytoma.Patients from seven centers with recurrent or progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223cdf241f0e8ec83b5ac21f67b650b3
https://doi.org/10.1023/a:1026211620793
https://doi.org/10.1023/a:1026211620793
Autor:
Mark Clemons, Sasha Mazzarello, Susan Dent, Iryna Kuchuk, Nathaniel Bouganim, Jessica Grinspan, Kathleen Beusterien, Lisa Vandermeer, Stan Z. Gertler
Objective. Our objective was to evaluate preferences associated with grade I/II and grade III/IV chemotherapy side effects among breast cancer patients receiving chemotherapy. We also assessed trade-offs that patients are willing to make between trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7ab7be1da869f52d94e4819c6a890d1
https://europepmc.org/articles/PMC3926796/
https://europepmc.org/articles/PMC3926796/